INS and Alzheimer disease: However, it is accepted that metformin improves mitochondrial defects, promotes the autophagy, and regulates insulin sensitization through the modulation of different intracellular pathways and consequently could improve LOAD neuropathology in preclinical AD models [104,105,106,107].